abstract |
An estrogen receptor modulator compound is provided. A compound having a structure of the following formula, a pharmaceutical composition containing the compound, and a medicament. The above compounds alone or other compounds for treating estrogen receptor-mediated or dependent diseases or conditions such as breast cancer, ovarian cancer, endometrial cancer, prostate cancer, lung cancer or uterine cancer To use in combination with. [Selection figure] None |